Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASR | P41180 | 1/20 | 0.56 |
| ▸ | HTR1A | P08908 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.42 |
| ▸ | HTR6 | P50406 | 1/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.36 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 2/20 | 0.35 |
| ▸ | HTR2C | P28335 | 2/20 | 0.35 |
| ▸ | HRH1 | P35367 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30112409 | 0.81 | CASR (0.50) | CASRHTR1AHPGDNISCHBRD4 | |
| SCHEMBL17150937 | 0.81 | CASR (0.50) | CASRHTR1AHPGDNISCHBRD4 | |
| SCHEMBL15158184 | 0.80 | HPGD (0.48) | CASRHTR1AHPGDNISCHBRD4 | |
| SCHEMBL4824743 | 0.79 | HPGD (0.51) | CASRHTR1AHPGDNISCHBRD4 | |
| SCHEMBL2638179 | 0.78 | CASR (0.47) | CASRHTR1AHPGDNISCHBRD4 | |
| SCHEMBL3969660 | 0.78 | CASR (0.47) | CASRHTR1AHPGDNISCHBRD4 | |
| SCHEMBL8570483 | 0.78 | CASR (0.47) | CASRHTR1AHPGDNISCHBRD4 | |
| SCHEMBL3969657 | 0.78 | CASR (0.47) | CASRHTR1AHPGDNISCHBRD4 | |
| SCHEMBL8562491 | 0.77 | CASR (0.47) | CASRHTR1AHPGDNISCHBRD4 | |
| SCHEMBL8562492 | 0.77 | CASR (0.47) | CASRHTR1AHPGDNISCHBRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5112820-A | Vision defects | STERLING DRUG INC. (US) | 1992-05-12 | — | — | US | disclosed |
| US-5109135-A | 2- or 3-aminomethyl-4-amino-3,4-dihydro-2H-1,4-benzoxazine intermediates | STERLING DRUG INC. (US) | 1992-04-28 | — | — | US | disclosed |
| US-5066803-A | Chemical intermediates for analgesics | STERLING DRUG INC. (US) | 1991-11-19 | — | — | US | disclosed |
| WO-1990007505-A1 | 2- AND 3-AMINOMETHYL-6-ARYLCARBONYL-2,3-DIHYDROPYRROLO[1,2,3-de]-1,4-BENZOXAZINES | STERLING DRUG INC. (US) | 1990-07-12 | — | — | WO | disclosed |
| US-4939138-A | 2- and 3-aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo(1,2,3-DE)-1,4-benzoxazines | STERLING DRUG INC. (US) | 1990-07-03 | — | — | US | disclosed |